ABOS
Acumen Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.23
−3.80%Leverage
- Debt / equity
- 0.76x
- Net debt / equity
- -0.77x
- Debt / assets
- 0.31x
- Debt / EBITDA
- -0.26x
- Net debt / EBITDA
- 0.27x
Liquidity & coverage
- Current ratio
- 1.89x
- Quick ratio
- 1.89x
- Cash ratio
- 1.74x
- Interest coverage
- -24.65x
- EBITDA / interest
- -23.43x
- Working capital
- $40.0M
Cash & dividend
- FCF / debt
- -3.35x
- Cash flow / debt
- -3.35x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026